fr

CARMAT announces the first commercial implants of its Aeson® artificial heart outside the European Union

CARMAT files a clinical trial application with the French health authorities for its artificial heart

Download

Presentation of study results on anatomic compatibility

Download

Annual results in line with expectations

Download

CARMAT_appoints Valerie Leroy as Director of Marketing and IR

Download

CARMAT receives payment of over Ç4 million in public financia support

Download

CARMAT_appoints Henri Lachmann _to _its Board of Directors

Download

Assembly of the first clinical version of the artificial heart

Download

Agreement with Edwards Lifesciences

Download
Top of page